Personalized Video‐Based Educational Platform to Improve Stroke Knowledge: A Randomized Clinical Trial
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.124.035176 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Christopher G Favilla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology University of Pennsylvania Philadelphia PA USA. Hauptthemen laut MEDLINE: Patient Education as Topic, Stroke, Health Knowledge, Attitudes, Practice, Quality of Life. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Stroke knowledge is critical to treatment adherence and poststroke outcomes. Here, we aimed to quantify the impact of a personalized video‐based educational platform to test the hypothesis that it improves patient satisfaction and stroke knowledge. Methods and Results In a single‐center pilot randomized trial, all patients with stroke and caregivers received standard stroke education during the hospitalization, but half were randomized to receive access to MyStroke, a personalized educational platform that provided brief videos about their stroke, risk factors, medications, and poststroke lifestyle. Satisfaction, stroke knowledge, and quality of life were assessed 7, 30, and 90 days after discharge. A total of 120 subjects (96 patients and 24 caregivers) were randomized to standard education (n=59) or MyStroke. At 90 days post‐stroke, those who received MyStroke were more likely to be satisfied with the stroke education the received (90% versus 73%, P =0.05) and more likely to correctly identify their stroke cause (67% versus 32%, P =0.003). However, MyStroke was not associated with a difference in self‐reported quality of life (EuroQol Visual Analogue Scale: 80 versus 75, P =0.06) or general stroke knowledge (total Stroke Patient Education Retention: 5 versus 5, P =0.47). With respect to secondary end points, MyStroke increased risk factor awareness 7 and 30 days poststroke, but this difference was not significant at 90 days.
Conclusions
The MyStroke personalized video‐based education platform improved patient and caregiver satisfaction while improving some aspects of personalized stroke knowledge without improving general stroke knowledge. A multicenter trial is needed to confirm these results, clarify generalizability, and target clinically relevant metrics such as stroke recurrence or adherence. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05118503.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology University of Pennsylvania Philadelphia PA USA.
ORCID-Profile: Christopher G Favilla, Stephanie R Cummings, Laura A Stein, Banafsheh Shakibajahromi, Kelly L Sloane, Scott E Kasner
Förderung
- NINDS NIH HHS
Zitieren
APA
Favilla, C. G., Reehal, N., Cummings, S. R., Burdett, R., Stein, L. A., Shakibajahromi, B., Yuan, K., Sloane, K. L., & Kasner, S. E. (2024). Personalized Video‐Based Educational Platform to Improve Stroke Knowledge: A Randomized Clinical Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035176
Vancouver
Favilla CG, Reehal N, Cummings SR, Burdett R, Stein LA, Shakibajahromi B, et al. Personalized Video‐Based Educational Platform to Improve Stroke Knowledge: A Randomized Clinical Trial. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035176
BibTeX
@article{Favilla2024,
author = {Favilla, Christopher G and Reehal, Navpreet and Cummings, Stephanie R and Burdett, Rebecca and Stein, Laura A and Shakibajahromi, Banafsheh and Yuan, Kristy and Sloane, Kelly L and Kasner, Scott E},
title = {Personalized Video‐Based Educational Platform to Improve Stroke Knowledge: A Randomized Clinical Trial},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.124.035176}
}
EUVIMED